Virtu Financial LLC acquired a new stake in shares of Cutera, Inc. (NASDAQ:CUTR) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 6,394 shares of the medical device company’s stock, valued at approximately $290,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. BlackRock Inc. raised its stake in shares of Cutera by 33.2% during the fourth quarter. BlackRock Inc. now owns 2,015,640 shares of the medical device company’s stock valued at $91,409,000 after purchasing an additional 502,933 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Cutera by 49.4% in the fourth quarter. Bank of New York Mellon Corp now owns 218,421 shares of the medical device company’s stock worth $9,905,000 after buying an additional 72,223 shares during the last quarter. Rhumbline Advisers increased its stake in shares of Cutera by 110.3% in the fourth quarter. Rhumbline Advisers now owns 29,170 shares of the medical device company’s stock worth $1,323,000 after buying an additional 15,300 shares during the last quarter. Raymond James Financial Services Advisors Inc. bought a new stake in shares of Cutera in the fourth quarter worth $644,000. Finally, Arizona State Retirement System bought a new stake in shares of Cutera in the fourth quarter worth $1,059,000. Institutional investors own 95.29% of the company’s stock.
CUTR has been the subject of a number of research analyst reports. BidaskClub upgraded shares of Cutera from a “hold” rating to a “buy” rating in a research note on Tuesday, December 12th. Gabelli restated a “buy” rating on shares of Cutera in a research note on Friday, February 16th. Zacks Investment Research upgraded shares of Cutera from a “sell” rating to a “hold” rating in a research note on Tuesday, January 9th. Finally, Stephens initiated coverage on shares of Cutera in a research note on Tuesday, March 13th. They issued an “overweight” rating and a $60.00 price target for the company. One research analyst has rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Cutera presently has an average rating of “Buy” and an average target price of $45.00.
Cutera stock opened at $51.40 on Friday. The firm has a market capitalization of $700.20, a price-to-earnings ratio of 66.75, a price-to-earnings-growth ratio of 1.12 and a beta of 0.45. Cutera, Inc. has a 12 month low of $18.50 and a 12 month high of $55.00.
Cutera (NASDAQ:CUTR) last released its quarterly earnings data on Wednesday, February 14th. The medical device company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.33 by $0.09. The firm had revenue of $47.60 million during the quarter, compared to the consensus estimate of $43.96 million. Cutera had a net margin of 19.80% and a return on equity of 18.31%. The firm’s revenue was up 25.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.30 earnings per share. equities analysts forecast that Cutera, Inc. will post 1.1 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/04/07/virtu-financial-llc-invests-290000-in-cutera-inc-cutr.html.
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.